TELNIVOC-M 500
March 30, 2026
METASIK-500
March 31, 2026
RUZOBOLT
₹1,990.00
Composition:
Vildagliptin 50 mg + Metformin 1000 mg
Packaging Detail:
10 x 15
Description
A combination tablet for type 2 diabetes containing Vildagliptin (a DPP-4 inhibitor) and high-dose Metformin (1000 mg). It works through complementary mechanisms to improve glycemic control by increasing insulin secretion and reducing hepatic glucose production.
Indications
Indications
-
Type 2 diabetes mellitus when metformin or vildagliptin alone does not provide adequate glycemic control.
-
As an adjunct to diet and exercise for glycemic management.
Side Effects
Side Effects
-
Nausea, vomiting, and diarrhea (may be more pronounced with high-dose metformin).
-
Headache and dizziness.
-
Hypoglycemia (rare when used without sulfonylureas or insulin).
-
Pancreatitis (rare).
-
Joint pain (arthralgia).
Reviews 0
Related products
-
ASTORMEL-20
₹1,100.00 -
CEFLIDE-CV
₹3,200.00 -
CEFIMOX-CV 325
₹1,900.00
Reviews
There are no reviews yet.